{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:47:46Z","timestamp":1773326866656,"version":"3.50.1"},"reference-count":54,"publisher":"Japan Society for Clinical Immunology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. J. Clin. Immunol.","Jpn.J.clin.Immun"],"published-print":{"date-parts":[[2012]]},"DOI":"10.2177\/jsci.35.157","type":"journal-article","created":{"date-parts":[[2012,6,29]],"date-time":"2012-06-29T22:27:02Z","timestamp":1341008822000},"page":"157-167","source":"Crossref","is-referenced-by-count":5,"title":["Airway involvement in relapsing polychondritis","\u518d\u767a\u6027\u591a\u767a\u8edf\u9aa8\u708e\u306b\u304a\u3051\u308b\u6c17\u9053\u75c5\u5909\u306e\u81e8\u5e8a"],"prefix":"10.2177","volume":"35","author":[{"given":"Naoto","family":"AZUMA","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"972","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Piette, J.C., Vinceneux, P. : Relapsing polychondritis. Firestein, G.S., et al., eds. Kelley's textbook of rheumatology, 8<sup>th<\/sup> Ed., Saunders, Philadelphia, pp1629-1634, 2009.","DOI":"10.1016\/B978-1-4160-3285-4.10095-6"},{"key":"2"},{"key":"3","unstructured":"3) Pearson, C.M., et al. : Relapsing polychondritis. <i>N. Engl. J. Med<\/i>. <b>263<\/b> : 51-58, 1960."},{"key":"4"},{"key":"5"},{"key":"6"},{"key":"7","unstructured":"7) Dolan, D.L., et al. : Relapsing polychondritis. Analytical literature review and studies on pathogenesis. <i>Am J Med<\/i>. <b>41<\/b> : 285-299, 1966."},{"key":"8","unstructured":"8) Michet, C.J.Jr., et al. : Relapsing polychondritis. Survival and predictive role of early disease manifestations. <i>Ann. Intern. Med<\/i>. <b>104<\/b> : 74-78, 1986."},{"key":"9","unstructured":"9) Lang, B., et al. : Susceptibility to relapsing polychondritis is associated with HLA-DR4. <i>Arthritis Rheum<\/i>. <b>36<\/b> : 660-664, 1993."},{"key":"10","unstructured":"10) Zeuner, M., et al. : Relapsing polychondritis: clinical and immunogenetic analysis of 62 patients. <i>J Rheumatol<\/i>. <b>24<\/b> : 96-101, 1997."},{"key":"11","unstructured":"11) Stabler, T., et al. : Serum cytokine profiles in relapsing polychondritis suggest monocyte\/macrophage activation. <i>Arthritis Rheum<\/i>. <b>50<\/b> : 3663-3667, 2004."},{"key":"12","unstructured":"12) Foidart, J.M., et al. : Antibodies to type II collagen in relapsing polychondritis. <i>N Engl J Med<\/i>. <b>299<\/b> : 1203-1207, 1978."},{"key":"13","unstructured":"13) Ebringer, R., et al. : Autoantibodies to cartilage and type II collagen in relapsing polychondritis and other rheumatic diseases. <i>Ann Rheum Dis<\/i>. <b>40<\/b> : 473-479, 1981."},{"key":"14","unstructured":"14) Terato, K., et al. : Specificity of antibodies to type II collagen in rheumatoid arthritis. <i>Arthritis Rheum<\/i>. <b>33<\/b> : 1493-1500, 1990."},{"key":"15","unstructured":"15) Alsalameh, S., et al. : Preferential cellular and humoral immune reactivities to native and denatured collagen types IX and XI in a patient with fatal relapsing polychondritis. <i>J Rheumatol<\/i>. <b>20<\/b> : 1419-1424, 1993."},{"key":"16","unstructured":"16) Hansson, A.S., et al. : The occurrence of autoantibodies to matrilin 1 reflects a tissue-specific response to cartilage of the respiratory tract in patients with relapsing polychondritis. <i>Arthritis Rheum<\/i>. <b>44<\/b> : 2402-2412, 2001."},{"key":"17","unstructured":"17) Cremer, M.A., et al. : Auricular chondritis in rats. An experimental model of relapsing polychondritis induced with type II collagen. <i>J Exp Med<\/i>. <b>154<\/b> : 535-540, 1981."},{"key":"18","unstructured":"18) Hansson, A.S., et al. : A new animal model for relapsing polychondritis, induced by cartilage matrix protein (matrilin-1). <i>J Clin Invest<\/i>. <b>104<\/b> : 589-598, 1999."},{"key":"19","unstructured":"19) Buckner, J.H., et al. : Autoreactivity against matrilin-1 in a patient with relapsing polychondritis. <i>Arthritis Rheum<\/i>. <b>43<\/b> : 939-943, 2000."},{"key":"20","unstructured":"20) McAdam, L.P., et al. : Relapsing polychondritis: prospective study of 23 patients and a review of the literature. <i>Medicine (Baltimore)<\/i>. <b>55<\/b> : 193-215, 1976."},{"key":"21","unstructured":"21) Trentham, D.E., Le, C.H. : Relapsing polychondritis. <i>Ann Intern Med<\/i>. <b>129<\/b> : 114-122, 1998."},{"key":"22"},{"key":"23","unstructured":"23) Kempta, Lekpa, F., et al. : Serum cartilage oligomeric matrix protein (COMP) level is a marker of disease activity in relapsing polychondritis. <i>Clin Exp Rheumatol<\/i>. <b>28<\/b> : 553-555, 2010."},{"key":"24","unstructured":"24) Damiani, J.M., Levine, H.L. : Relapsing polychondritis&mdash;report of ten cases. <i>Laryngoscope<\/i>. <b>89<\/b> : 929-946, 1979."},{"key":"25","unstructured":"25) Mohsenifar, Z., et al. : Pulmonary function in patients with relapsing polychondritis. <i>Chest<\/i>. <b>81<\/b> : 711-717, 1982."},{"key":"26","unstructured":"26) Sarodia, B.D., et al. : Management of airway manifestations of relapsing polychondritis. Case reports and review of literature. <i>Chest<\/i>. <b>116<\/b> : 1669-1675, 1999."},{"key":"27","unstructured":"27) Lim, M.C., Chan, H.L. : Relapsing polychondritis&mdash;a report on two Chinese patients with severe costal chondritis. <i>Ann Acad Med Singapore<\/i>. <b>19<\/b> : 396-403, 1990."},{"key":"28","unstructured":"28) Krell, W.S., et al. : Pulmonary function in relapsing polychondritis. <i>Am Rev Respir Dis<\/i>. <b>133<\/b> : 1120-1123, 1986."},{"key":"29","unstructured":"29) Tillie-Leblond, I., et al. : Respiratory involvement in relapsing polychodritis. Clinical, functional, endoscopic, and radiographic evaluations. <i>Medicine (Baltimore)<\/i>. <b>77<\/b> : 168-176, 1998."},{"key":"30"},{"key":"31"},{"key":"32","unstructured":"32) Lee, K.S., et al. : Relapsing polychondritis : prevalence of expiratory CT airway abnormalities. <i>Radiology<\/i>. <b>240<\/b> : 565-573, 2006."},{"key":"33"},{"key":"34"},{"key":"35","unstructured":"35) Imanishi, Y., et al. : Relapsing polychondritis diagnosed by Tc-99m MDP bone scintigraphy. <i>Clin Nucl Med<\/i>. <b>24<\/b> : 511-513, 1999."},{"key":"36","unstructured":"36) Nishiyama, Y., et al. : [18F] fluorodeoxyglucose positron emission tomography imaging in a case of relapsing polychondritis. <i>J Comput Assist Tomogr<\/i>. <b>31<\/b> : 381-383, 2007."},{"key":"37","unstructured":"37) De Greeter, F., Vandecasteele, S.J. : Fluorodeoxyglucose PET in relapsing polychondritis. <i>N Engl J Med<\/i>. <b>358<\/b> : 536-537, 2008."},{"key":"38","unstructured":"38) Sato, M., et al. : F-18 FDG PET\/CT in relapsing polychondritis. <i>Ann Nucl Med<\/i>. <b>24<\/b> : 687-690, 2010."},{"key":"39","unstructured":"39) Nakano, Y., et al. : Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. <i>Am J Respir Crit Care Med<\/i>. <b>162<\/b> : 1102-1108, 2000."},{"key":"40","unstructured":"40) Kasahara, K., et al. : Correlation between the bronchial subepithelial layer and whole airway wall thickness in patients with asthma. <i>Thorax<\/i>. <b>57<\/b> : 242-246, 2002."},{"key":"41","unstructured":"41) Tsuburai, T., et al. : Use of inhaled fluticasone propionate to control respiratory manifestations of relapsing polychondritis. <i>Respirology<\/i>. <b>14<\/b> : 299-301, 2009."},{"key":"42","unstructured":"42) Mpofu, S., et al. : Treatment of respiratory complications in recalcitrant relapsing polychondritis with infliximab. <i>Rheumatology (Oxford)<\/i>. <b>42<\/b> : 1117-1118, 2003."},{"key":"43","unstructured":"43) Saadoun, D., et al. : Sustained response to infliximab in 2 patients with refractory relapsing polychondritis. <i>J Rheumatol<\/i>. <b>30<\/b> : 1394-1395, 2003."},{"key":"44","unstructured":"44) Richez, C., et al. : Successful treatment of relapsing polychondritis with infliximab. <i>Clin Exp Rheumatol<\/i>. <b>22<\/b> : 629-631, 2004."},{"key":"45","unstructured":"45) Carter, J.D. : Treatment of relapsing polychondritis with a TNF antagonist. <i>J Rheumatol<\/i>. <b>32<\/b> : 1413, 2005."},{"key":"46","unstructured":"46) Seymour, M.W., et al. : Prolonged response to anti-tumour necrosis factor treatment with adalimumab (Humira) in relapsing polychondritis complicated by aortitis. <i>Rheumatology (Oxford)<\/i>. <b>46<\/b> : 1738-1739, 2007."},{"key":"47","unstructured":"47) Kawai, M., et al. : Sustained response to tocilizumab, anti- interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis. <i>Rheumatology (Oxford)<\/i>. <b>48<\/b> : 318-319, 2009."},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Narshi, C.B., Allard, S.A. : Sustained response to tocilizumab, anti-IL-6 antibody, following anti-TNF-&alpha; failure in a patient with relapsing polychondritis complicated by aortitis. <i>Rheumatology (Oxford)<\/i>. 2012. [Epub ahead of print]","DOI":"10.1093\/rheumatology\/ker451"},{"key":"49","unstructured":"49) Moulis, G., et al. : Abatacept for relapsing polychondritis. <i>Rheumatology (Oxford)<\/i>. <b>49<\/b> : 1019, 2010."},{"key":"50","unstructured":"50) Leroux, G., et al. : Treatment of relapsing polychondritis with rituximab: a retrospective study of nine patients. <i>Arthritis Rheum<\/i>. <b>61<\/b> : 577-582, 2009."},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Kemta, Lekpa, F., et al. : Biologics in relapsing polychondritis : a literature review. Semin Arthritis Rheum. 2011. [Epub ahead of print]","DOI":"10.1016\/j.semarthrit.2011.08.006"},{"key":"52","unstructured":"52) Manna, R., et al. : Relapsing polychondritis with severe aortic insufficiency. <i>Clin Rheumatol<\/i>. <b>4<\/b> : 474-480, 1985."},{"key":"53","unstructured":"53) Adliff, M., et al. : Treatment of diffuse tracheomalacia secondary to relapsing polychondritis with continuous positive airway pressure. <i>Chest<\/i>. <b>112<\/b> : 1701-1704, 1997."},{"key":"54"}],"container-title":["Japanese Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/35\/3\/35_157\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T23:14:55Z","timestamp":1642634095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/35\/3\/35_157\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.2177\/jsci.35.157","relation":{},"ISSN":["0911-4300","1349-7413"],"issn-type":[{"value":"0911-4300","type":"print"},{"value":"1349-7413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}